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In Brief
Anaphase-promoting complex/
cyclosome (APC/C) is an essential
regulator of mitosis in eukaryotes. Wild
et al. show that the APC/C subunits APC7
and APC16 are not required for mitosis in
normal cells. However, genetic deletion of
these subunits provides synthetic
viability to cells lacking the spindle
assembly checkpoint.
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The multisubunit ubiquitin ligase APC/C (anaphase-
promoting complex/cyclosome) is essential for
mitosis by promoting timely degradation of cyclin
B1. APC/C is tightly regulated by the spindle assem-
bly checkpoint (SAC), which involves MPS1 and
MAD2-dependent temporal inhibition of APC/C. We
analyzed the contribution of the APC/C subunits
APC7 and APC16 to APC/C composition and func-
tion in human cells. APC16 is required for APC7 as-
sembly into APC/C, whereas APC16 assembles inde-
pendently of APC7. APC7 and APC16 knockout cells
display no major defects in mitotic progression,
cyclin B1 degradation, or SAC response, but APC/C
lacking these two subunits shows reduced ubiquity-
lation activity in vitro. Strikingly, deletion of APC7 or
APC16 is sufficient to provide synthetic viability to
MAD2 deletion.DAPC7DMAD2 cells display acceler-
ated mitosis and require SAC-independent MPS1
function for genome stability. These findings reveal
that the composition of APC/C critically influences
the importance of the SAC in humans.
INTRODUCTION
Eukaryotic cells depend on the activity of the anaphase-pro-
moting complex/cyclosome (APC/C), a multi-subunit ubiquitin
ligase, to progress through mitosis (Pines, 2011; Primorac and
Musacchio, 2013). Among a variety of mitotic APC/C substrates,
only securin and cyclin B1 are essential for mitotic progression in
yeast (Thornton and Toczyski, 2003). APC/C requires the co-
activator CDC20 and an E2 enzyme, UBE2C or UBE2D, to initiateCell Repo
This is an open access article undcyclin B1 ubiquitylation (Hershko et al., 1994; Townsley et al.,
1997; Wild et al., 2016; Yu et al., 1996). After transferring initial
ubiquitin onto substrates, APC/C functions with UBE2S to pro-
mote K11-linked polyubiquitylation, which enhances substrate
degradation efficiency (Garnett et al., 2009; Meyer and Rape,
2014; Min et al., 2015; Williamson et al., 2009; Wu et al., 2010).
Lowering APC/C activity delays mitotic progression, whereas
loss of APC/C activity is lethal (Magnuson and Epstein, 1984;
Wirth et al., 2004).
The timing of APC/C-initiated securin and cyclin B1 degrada-
tion is of critical importance for the faithful segregation of chro-
mosomes. Proper timing is achieved by the spindle assembly
checkpoint (SAC), which coordinates bipolar chromosome
attachment to the mitotic spindle with APC/C-mediated securin
and cyclin B1 ubiquitylation (London and Biggins, 2014; Sivaku-
mar and Gorbsky, 2015). The SAC is activated by recruitment of
MPS1 to unattached kinetochores (Hiruma et al., 2015; Ji et al.,
2015). Subsequently, MPS1-catalyzed phosphorylation events
recruit SAC proteins to unattached kinetochores and promote
formation of the mitotic checkpoint complex (MCC), consisting
of MAD2, CDC20, BUBR1, and BUB3 (Sudakin et al., 2001).
MCC binding to APC/C blocks substrate recognition by
CDC20 and hampers access to UBE2C (Alfieri et al., 2016;
Yamaguchi et al., 2016). Although SAC function is conserved
from yeast to human, its activity is of different importance in
different organisms; deletion of SAC proteins, such as MAD2,
is compatible with viability in yeast and Drosophila but
leads to severe genomic instability in mice and human cells
that is incompatible with life (Buffin et al., 2007; Dobles et al.,
2000; Kops et al., 2005; Meraldi et al., 2004; Michel et al.,
2001; 2004).
The human APC/C consists of 19 subunits composed of 14
distinct proteins. The atomic architecture of APC/C reveals
that APC1 and APC2 form the core of the platform, whereas
the tetratricopeptide repeat (TPR) subunits APC3, APC6,rts 25, 2317–2328, November 27, 2018 ª 2018 The Authors. 2317
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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  SILAC ratio  
APC subunits  (APC / Ctr)  (APCΔAPC7/ Ctr)  (APC
ΔAPC7 / 
APC) 
APC1 25.18 26.20 1.06 
APC2 25.60 25.29 1.00 
APC3 17.53 20.03 1.12 
APC4 19.98 21.46 1.06 
APC5 19.34 21.23 1.07 
APC6 19.58 21.37 1.08 
APC7 40.15 n.d. n.d. 
APC8 16.65 20.91 1.25 
APC10 22.13 24.07 1.07 
APC12 31.06 32.59 1.08 
APC13 23.05 25.71 1.15 
APC15 23.40 24.69 1.07 
APC16 19.04 16.50 0.84 
 SILAC ratio 
APC subunits  (APC / Ctr)  (APC
ΔAPC16/ 
Ctr) 
 (APCΔAPC16 / 
APC) 
APC1 20.71 26.39 1.27 
APC2 22.39 22.88 1.01 
APC3 21.58 18.00 0.83 
APC4 20.15 24.26 1.17 
APC5 19.42 22.88 1.14 
APC6 21.84 20.45 0.90 
APC7 14.21 0.14 0.01 
APC8 14.64 24.24 1.63 
APC10 23.30 20.99 0.79 
APC12 26.64 21.55 0.84 
APC13 14.60 21.04 1.40 
APC15 16.05 29.51 1.91 
APC16 34.43 n.d. n.d. 
SILAC:
Cell line:
(legend on next page)
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APC7, and APC8 constitute the majority of the ‘‘arc lamp’’
(Chang et al., 2015). The catalytic center of APC/C is formed
by APC11 and APC2 along with APC10 and the co-activators
CDC20 or CDH1 for substrate recognition. APC/C composition
is conserved from yeast to human, except for the two subunits,
APC7 and APC16, located at the tip of the arc lamp (Chang
et al., 2015). APC7 is present in two copies and, together with
one APC16 molecule, sits on top of APC3. APC16 is implicated
in mitotic progression and APC/C substrate stability but not
APC/C assembly (Kops et al., 2010; Shakes et al., 2011). Deple-
tion of APC7 in Drosophila melanogaster had a limited effect on
mitotic progression, and an APC7 null strain is viable (Pa´l et al.,
2007). In vitro, it has been shown that APC3 forms a sub-com-
plex with APC7 and that this sub-complex is stabilized by
APC16 (Yamaguchi et al., 2015). Based on these data, the au-
thors suggest that the APC3/APC7/APC16 sub-complex may
constitute an assembly unit or that APC16 recruits APC7 onto
APC3. Here we set out to analyze the contribution of APC7
and APC16 to APC/C assembly, function, and regulation using
human genetic knockouts cells.
RESULTS
APC16 Is Required for APC7 Assembly into APC/C
In Vivo
To study the effect of APC7 and APC16 on the composition of
APC/C in vivo, we fused mCherry to the C terminus of APC8
and investigated APC/C composition by affinity purification
mass spectrometry (AP-MS). Because APC8 is essential for
cell viability, biallelic tagging of the gene indicated functional
integrity of APC8-mCherry-tagged APC/C. Next, we individually
deleted APC7 and APC16 in the APC8-mCherry cell line (Figures
S1A and S1B) and analyzed APC/C composition with stable
isotope labeling by amino acids in cell culture (SILAC)-based
AP-MS (Figure 1A). We purified APC/C from wild-type and
DAPC7 cells by APC8-mCherry affinity purification. In wild-type
cells, all detected APC/C subunits were enriched (>2-fold)
(Figure 1B; Table S1), demonstrating proper incorporation of
APC8-mCherry into APC/C complexes. All APC/C subunits,
except for APC7, co-purify with APC8-mCherry from DAPC7
cells, showing that the remaining APC/C subunits assemble in
the absence of APC7 (Figure 1B). We confirmed APC/C assem-
bly in DAPC7 cells by immunoblotting (Figure 1C). We used aFigure 1. APC16 Is Required for Assembly of APC7 into APC/C
(A) Experimental setup forMS-based analysis of APC/C composition. APC8-mChe
DAPC16 cells were labeled with heavy SILAC. APC/C was purified using mCherr
SILAC-labeled cells.
(B) SILAC ratios for APC/C subunits enriched from APC8-mCherry wild-type and A
wild-type (medium SILAC) and DAPC7 cells (heavy SILAC) and analyzed by MS. M
The table shows combined SILAC ratios for APC/C subunits detected in three te
(C) Analysis of APC/C composition in DAPC7 cells. APC/C was purified via APC
(from two independent DAPC7 clonal cell lines) and subsequently analyzed by im
control for unspecific binding to the affinity beads. GAPDH levels were analyzed
(D) SILAC ratios for APC/C subunits enriched from APC8-mCherry and APC8-m
(E) Immunoblot analysis of APC/C composition in DAPC16 cells with the indicate
mCherry cells and from APC8-mCherry DAPC16 cells. The indicated samples w
Wild-type cells were used as a control for unspecific binding to the affinity bead
See also Figure S1.similar AP-MS approach to analyze the role of APC16 in
APC/C assembly. Interestingly, APC/C enriched from DAPC16
cells not only lacked APC16 but also APC7 (Figure 1D; Fig-
ure S1C; Table S1). To test whether lack of APC7 was due to
the loss of APC16, we expressed APC16-EGFP in DAPC16 cells
and analyzed APC/C composition (Figure 1E). Consistent with
its integration into APC/C (Kops et al., 2010), APC16-EGFP
co-purified with APC8-mCherry and, indeed, restored APC7
co-purification with APC8-mCherry. Together, these results
show that, in vivo, APC16 incorporates into APC/C in the
absence of APC7, whereas APC7 requires APC16 for incorpora-
tion into APC/C.
APC/C Lacking APC7 andAPC16Are Less Active In Vitro
We next tested whether APC/C lacking APC7 or APC7 and
APC16 display altered ubiquitylation activity. For this, we immu-
noprecipitated APC/C from wild-type, DAPC7, and DAPC16
cells in an anaphase-like state and analyzed APC/C activity, in
the presence of the two E2 enzymes UBE2C and UBE2S,
toward securin (Hellmuth et al., 2014). Compared with wild-
type APC/C, a decrease in higher molecular securin species
was observed upon incubation with APC/C purified from either
DAPC7 or DAPC16 cells (Figures 2A and 2B; Figure S1D). Simi-
larly, APC/C purified from DAPC7 and DAPC16 cells showed
reduced ubiquitylation activity toward cyclin B1, particularly
apparent at longer incubation times (Figures 2C and 2D; Fig-
ure S1E). Overall, these results revealed slightly reduced ubiqui-
tylation activity of APC/C lacking APC7 or APC7 and APC16
toward two of its substrates, securin and cyclin B1, in vitro.
Cells Lacking Either APC7 or APC16 Display No Major
Defects in Mitotic APC/C Function
To analyze the role of APC7 and APC16 in mitotic progression,
we endogenously tagged histone H2B with mVenus and cyclin
B1 with mCerulean3 in the wild-type, DAPC7, and DAPC16
background (Figures S2A–S2C) and analyzed mitotic timing by
time-lapse microscopy. No significant difference was observed
for mitotic timing (defined as the timing from nuclear cyclin B1
influx to anaphase onset) between wild-type, DAPC7, and
DAPC16 cells (Figure 3A; Figure S2C). Concordantly, no signifi-
cant alteration was found in the kinetics of mitotic cyclin B1
degradation between wild-type and APC7 or APC16 knockout
cells (Figure 3B). Hence, the slightly reduced APC/C activityrry-expressing wild-type cells were labeled withmediumSILAC, andDAPC7 or
y affinity beads, and as a control, a mock pull-down was performed from light
PC8-mCherryDAPC7 cells. APC/Cwas purified with mCherry pull-downs from
ock pull-down from wild-type HCT116 cells served as a control (light SILAC).
chnical replicates (n.d., not determined).
8-mCherry pull-downs from APC8-mCherry and APC8-mCherry DAPC7 cells
munoblotting using the indicated antibodies. Wild-type cells were used as a
to verify equal amounts of input for the different cell lines.
Cherry DAPC16 cells. The analysis was performed as described in (B).
d antibodies. APC/C was purified via APC8-mCherry pull-downs from APC8-
ere transiently transfected with APC16-EGFP 32 hr prior to APC/C pull-down.
s.
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Figure 2. Analysis of In Vitro Ubiquitylation Activities of APC/C Lacking APC16 and/or APC7
(A) Ubiquitylation activity of purified APC/C variants toward securin. APC/C was purified from APC8-mCherry (WT), DAPC7 APC8-mCherry (DAPC7), or DAPC16
APC8-mCherry (DAPC16) cells using an antibody against APC3 and incubated for different times with recombinant securin supplemented with UBE2C and
UBE2S as indicated. Ubiquitylation of securin was analyzed by an a-securin immunoblot. A representative result from two experiments is shown. WT, wild-type;
DN, dominant-negative.
(B) Immunoblot analysis of the purified APC/C used for Figure 2A. Input, supernatant, and immunoprecipitated fractions (immunoprecipitation [IP]: APC3) from the
indicated cell lines were analyzed with the indicated antibodies.
(C) Ubiquitylation activity of purified APC/C variants toward cyclin B1 as described in (A). Ubiquitylation of cyclin B1 was analyzed by an a-cyclin B1 immunoblot.
A representative result from two experiments is shown.
(D) Immunoblot analysis of the purification of APC/C used for Figure 2C, analyzed as described in (B).
See also Figure S1.upon loss of APC7 or APC7 and APC16, measured in vitro, does
not elicit a discernable effect on mitotic timing and cyclin B1
degradation in vivo.
Next, we assessed the responsiveness of DAPC7 and
DAPC16 cells to SAC activation. Cells were treated with nocoda-
zole, and the cellular DNA content was analyzed by flow cytom-
etry (fluorescence-activated cell sorting [FACS]) (Figure S3A).
For all analyzed cell lines, nocodazole treatment caused a2320 Cell Reports 25, 2317–2328, November 27, 2018marked increase in the number of cells with 4N DNA, showing
that DAPC7 and DAPC16 cells remain sensitive to SAC
signaling. To further verify SAC functionality in DAPC7 cells, we
analyzed the nocodazole-dependent association of SAC-gener-
ated MCC with APC/C. For both wild-type and DAPC7 cells,
increased enrichment of the SAC proteins BUB3, BUBR1,
CDC20, and MAD2 was observed in APC8-mCherry pull-downs
upon nocodazole-induced mitotic arrest (Figures 3C and 3D).
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We next assayed the robustness of the SAC response in DAPC7
and DAPC16 cells using live-cell imaging (Figure S3B). These
data revealed no difference in SAC robustness between wild-
type and DAPC16 cells and indicated a slightly less robust
SAC in DAPC7 cells. To analyze the dependence of DAPC7
and DAPC16 cells on SAC function for genomic stability, we
treated the cell lines with the MPS1 inhibitor reversine and
analyzed cellular ploidy by FACS (Figure S3C). Reversine treat-
ment increased the number of polyploid cells (>4NDNA content),
demonstrating the importance of MPS1 activity for maintaining
genome stability in these cell lines. To independently assess
the importance of SAC function in DAPC7 and DAPC16 cells,
we depleted MAD2 by RNAi and analyzed nuclear morphology
4 days thereafter (Figure 3E; Figure S3D). Consistent with the
crucial role of MAD2 in maintaining genomic stability, MAD2-
depleted wild-type cells showed a marked decrease in normally
sized and shaped nuclei (Figure 3F). Interestingly, however, the
appearance of enlarged multi-lobed nuclei upon MAD2 RNAi
was mitigated in both DAPC7 and DAPC16 cells (Figure 3F).
Overall, these results indicate that loss of APC7 or APC16 has
little effect on mitotic progression, APC/C activity toward cyclin
B1, and SAC functionality. However, cell lines lacking either
APC7 or APC16 appear to rely less onMAD2 formaintaining their
genome stability.
Genetic Ablation of MAD2 in APC7 or APC16 Knockout
Cells
Because theDAPC7 andDAPC16 cell lines displayed less severe
effect ofMAD2 depletion on their genome stability (Figure 3F), we
tested whether genetic ablation of MAD2 is tolerated in these cell
lines. To assess the synthetic viability of MAD2 deletion with the
loss of APC7, we mixed equal numbers (i.e., 1:1:1) of wild-type,
APC8-mCherry, and APC8-mCherryDAPC7 cells (Figure 4A; Fig-
ure S4A) and performed CRISPR-mediated MAD2 deletion in the
resulting mixed cell population. After selection, single colonies
were analyzed for the absence of MAD2 by immunoblotting.
We recovered a total of six DMAD2 cell lines, all of which wereFigure 3. Analysis of Mitotic APC/C Function in DAPC7 and DAPC16 C
(A) Time between nuclear cyclin B1 influx and anaphase onset for the indicated c
histone H2B and mCerulean3-tagged cyclin B1 were imaged every 5 min. The da
cells. Cells with identical timing are depicted as a box, and the size of each box
of the respective cell line. The mean timing and SD are stated on the top. The me
are shown, and the number (n) of analyzed cells is stated for each cell line. A two-t
non-significant).
(B) Cyclin B1 degradation rates around anaphase onset in the indicated cell lines
rates for individual cells from the indicated genetic backgrounds. Cyclin B1 degra
measured decrease in cyclin B1-mCerulean3 intensities around anaphase onset.
rate is drawn as a black line. A two-tailed t test was performed to calculate signifi
degradation rate and its SD in the indicated cell lines.
(C) SILAC ratios for APC/C andMCC subunits detected inMS analysis of APC8-m
mCherry pull-downs from untreated cells (medium SILAC) and from cells treat
combined SILAC ratios from three technical replicates. A control pull-down from l
(D) SILAC ratios for APC/C and MCC subunits detected in MS analysis of
described in (C).
(E) The indicated cell lines were treated with control small interfering RNA (siR
Representative images from one of the three independent experiments are show
(F) Quantification of normal nuclei from the experiments described in (E). From
cumulative percentage of normal nuclei from all three experiments is shown. Err
See also Figures S2 and S3.
2322 Cell Reports 25, 2317–2328, November 27, 2018derived from the APC8-mCherryDAPC7 background (Figure 4B).
Not retrieving MAD2 knockout clones from wild-type back-
grounds is consistent with MAD2 being essential in human cells.
Identification of multiple MAD2 knockout cell lines in the DAPC7
background demonstrates that cells lacking APC7 can tolerate
loss of MAD2. To confirm the observed synthetic viability and
to assess whether it also applies to APC16 deletion, we devised
an approach facilitating direct deletion of MAD2 from wild-type
cells along with co-deletion of either APC7 or APC16. For this,
we GFP-tagged endogenous MAD2 and transfected these cells
with a MAD2 deletion construct bearing a selection marker as
well as with a selection-less plasmid encoding a guide RNA tar-
geting either APC7 or APC16 (Figure 4C; Figure S4B). After selec-
tion, cell colonies were isolated based on the visually observed
loss of GFP fluorescence (indicating loss of MAD2-GFP), and
the absence of MAD2-GFP was subsequently confirmed by
immunoblotting. Concurrent loss of APC7 and APC16 was as-
sessed by immunoblotting and genotyping, respectively. Using
this approach, we obtained four DMAD2-GFPDAPC7 and six
DMAD2-GFPDAPC16 cell lines (Figure 4D; Figures S4C and
S4D). Because the experimental setup only selects for MAD2
deletion, the strict co-deletion of either APC7 or APC16 with
MAD2 deletion indicates that the observed viability is synthetic.
Consistent with an essential role of MAD2 in SAC activity, neither
DAPC7DMAD2 nor DMAD2-GFPDAPC16 cells arrested in
mitosis upon nocodazole treatment (Figure 4E; Figure S4E).
Together, these results show that deletion of either APC7 or
APC16 allows for continuedproliferation in the absence ofMAD2.
Analysis of Cells Lacking MAD2
Loss of SAC activity leads to genomic instability (Dobles et al.,
2000; Kops et al., 2005; Figures 3E and 3F). We therefore
analyzed the cellular DNA content of different DAPC7DMAD2
andDMAD2-GFPDAPC16 clonal cell lines by FACS (Figure S5A).
A modest increase in polyploid cells was observed in the
SAC-deficient cell lines comparedwith wild-type cells, indicating
ongoing but tolerable chromosomal instability. To furtherells
ell lines. Wild-type, DAPC7, and DAPC16 cell lines expressing mVenus-tagged
ta show the time from nuclear cyclin B1 influx to anaphase onset for individual
is scaled according to the percentage they contribute to the whole population
dian timing is drawn as a black line. Results of three independent experiments
ailed t test was performed to calculate significance (p < 0.01 = significant; n.s.,
(data from the experiment shown in A). The plot shows cyclin B1 degradation
dation rates in individual cells were calculated by the slope of a linear fit for the
The number of analyzed cells is given as n. The median cyclin B1 degradation
cance (p < 0.01 = significant). The table on the right shows the mean cyclin B1
Cherry pull-downwith or without SAC activation. APC/Cwas purified via APC8-
ed with 200 nM nocodazole (noc) for 18 hr (heavy SILAC). Depicted are the
ight SILAC was used as a reference for unspecific binding to the affinity beads.
APC8-mCherry pull-down from APC8-mCherry DAPC7 cells, analyzed as
NA) or MAD2-targeting siRNA for 96 hr, stained with Hoechst, and imaged.
n. The scale bar indicates 10 mm.
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or bars depict SD from 3 experiments.
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explore the genomic stability of DAPC7DMAD2 cells, we
compared mitosis and chromosome segregation in wild-type,
DAPC7DMAD2, and wild-type cells depleted of MAD2 by
RNAi. To this end, we fluorescently tagged histone H2B in
wild-type and DAPC7DMAD2 cells and analyzed them by live-
cell imaging (Figure 5A). We observed a decreased time from
chromatin condensation to anaphase onset in DAPC7DMAD2
cells compared with wild-type cells, consistent with the function
of MAD2 in delaying mitotic progression in wild-type cells
(Figure 5B). Wild-type cells depleted of MAD2 by RNAi most
frequently (85%) proceeded through mitosis without formation
of a metaphase plate, resulting in aberrant or undetectable
chromosome segregation (Figures 5A and 5C; Figure S5B).
In contrast, DAPC7DMAD2 cells frequently (96%) formed a
metaphase plate despite lacking MAD2 function and segregated
chromosomes (Figures 5A and 5C). Compared with wild-
type cells, we captured more chromosome segregation errors
in DAPC7DMAD2 cells (Figure 5C; Figure S5B), indicating an
increased rate of ongoing segregation errors.
Because MPS1 acts upstream of MAD2 in the SAC response,
we tested whether ablation of MAD2 would relieve cells of the
need for MPS1 kinase activity to maintain their genome stability.
FACS analysis of reversine-treated DAPC7DMAD2 or DMAD2-
GFPDAPC16 cells showed a marked increase in cells with
more than 4N DNA content (Figure 5D). To analyze the effect
of reversine on cyclin B1 degradation in DAPC7DMAD2 cells,
we fluorescently tagged cyclin B1 in this background along
with a corresponding wild-type control (Figure S5C). Consistent
with themitotic timing shown in Figure 5B, cyclin B1 degradation
was accelerated in DAPC7DMAD2 cells compared with wild-
type cells (Figure 5E). As expected, reversine treatment
significantly accelerated the onset of cyclin B1 degradation in
wild-type cells. In contrast, reversine did not accelerate cyclin
B1 degradation in DAPC7DMAD2 cells. Hence, MAD2 deletion
eliminates the mitotic timing function of MPS1 but does not
relieve these cell lines of the need for MPS1 activity to prevent
excessive polyploidy. Consistent with the SAC independence
of DAPC7DMAD2 cells, BUBR1 depletion by RNAi did not accel-
erate cyclin B1 degradation in these cells, in marked contrast to
wild-type cells (Figures S5D and S5E). In summary, cells lackingFigure 4. Loss of APC7 or APC16 Provides Synthetic Viability to MAD2
(A) Strategy for assessing the synthetic viability of MAD2 deletion with the DAPC
DAPC7 cells were mixed and seeded together, resulting in a mixed cell populat
targeted by CRISPR/Cas9 using a drug-selectable donor plasmid designed to d
immunoblotting to assess loss of MAD2 and to determine its parent-of-origin ce
(B) Analysis of APC7 and MAD2 expression in the six clonal DMAD2 cell lines retr
Note that all six retrieved clonal cell lines derive from APC8-mCherry DAPC7 cel
(C) Scheme of the CRISPR/Cas9-based MAD2-GFP synthetic viability assay. Cell
with a drug-selectable deletion cassette for theMAD2 gene along with a drug selec
drug selection, cell colonies were microscopically inspected for loss of MAD2-GFP
immunoblotting for loss of MAD2 expression. The status of APC7 and APC16 in
genomic locus, respectively.
(D) Immunoblot analysis of the four clones retrieved from the MAD2-GFP synthet
Note that all retrieved clonal cell lines lost expression of APC7.
(E) Analysis of SAC functionality in DAPC7DMAD2 and DMAD2-GFPDAPC16 cells
with or without 18 hr of 200 nM nocodazole, was stained with propidium iodide an
type HCT116 cells for comparison. The tables at the top show the percentage of
panel shows the corresponding flow cytometry profiles from the indicated cell lin
See also Figure S4.
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increased chromosome segregation errors and require MPS1
activity for genome stability in the absence of a functional SAC.
DISCUSSION
APC/C is the largest known ubiquitin ligase in human cells. How
this complex assembles in vivo is not fully understood. Our work
shows that APC16 is required for APC7 assembly into APC/C
in vivo and that APC16 can incorporate into APC/C independent
of APC7. Gratifyingly, these results are in line with in vitro data on
an APC3/APC7/APC16 sub-complex (Yamaguchi et al., 2015).
Analysis of key aspects of APC/C function, namely mitotic
timing, cyclin B1 degradation, and response to spindle assembly
defects, revealed no significant alterations upon loss of either
APC7 or APC16. It has been reported previously that RNAi-
based depletion of APC16 in HeLa cells and C. elegans results
in mitotic defects (Kops et al., 2010). It is currently unclear why
APC16 knockdown and APC16 deletion result in different pheno-
types, but the difference between acute and permanent lossmay
contribute to this discrepancy. Another possibility is that cells
require stronger activity of APC/C in polyploid cells compared
with haploid or diploid cells cultured in vitro.
The major phenotype detected in APC7 or APC16 knockout
cells is their reduced dependence on MAD2 function for viability,
indirectly revealing a functional effect of these APC/C subunits in
HCT116 cells. The penetrance of genome instability upon MAD2
depletion by RNAi is significantly reduced in DAPC7 and
DAPC16 cells compared with wild-type HCT116 cells. We spec-
ulate that this reduced dependence onMAD2 function ultimately
allows tolerance of MAD2 deficiency in the DAPC7 and DAPC16
cell lines. The synthetic viability between the loss of MAD2 and
deletion of either APC7 or APC16 may be particularly notable
given that no measurable increase is observed in the mitotic
length in DAPC7 and DAPC16 cells. Our previous work showed
that deletion of two APC/C-employed E2 enzymes, UBE2S and
UBE2C, provides viability to MAD2 deletion (Wild et al., 2016).
DUBE2SDUBE2C cells display significantly prolonged mitosis,
and it was therefore rationalized that it is this increased length
of mitosis that enables cells to properly segregate chromosomesDeletion
7 genotype. Equal numbers of wild-type, APC8-mCherry, and APC8-mCherry
ion with one-third of cells lacking APC7. The genomic MAD2 locus was then
isrupt the MAD2 gene. After selection, each clonal cell line was analyzed by
ll line.
ieved from the setup outlined in (A). GAPDH levels served as a loading control.
ls.
s expressing endogenously GFP-tagged MAD2 (MAD2-GFP) were transfected
tion-less plasmid encoding a guide RNA targeting either APC7 or APC16. After
fluorescence. Cell colonies lacking green fluorescence were then analyzed by
MAD2-deficient cells was assessed by immunoblotting or sequencing of the
ic viability assay performed in combination with an APC7 targeting guide RNA.
. Cellular DNA fromwild-type,DAPC7DMAD2, and DMAD2-GFPDAPC16 cells,
d analyzed by flow cytometry. MAD2 depletion by RNAi was performed in wild-
cells with the respective (2N, 2N-4N, 4N, and >4N) DNA content. The bottom
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in the absence of SAC activity. In contrast, mitosis was not de-
tectably prolonged in DAPC7 and DAPC16 cells, but these ge-
netic backgrounds provide synthetic viability to MAD2 deletion.
Therefore, even a mild reduction in APC/C activity, which may
be below the detection limit of our live-cell assay, may suffice
to render MAD2 function non-essential in DAPC7 and DAPC16
cells. This idea is supported by our analysis of APC/C activity
in vitro, which revealed a small but discernible decrease in
APC/C activity when APC7 or APC7 and APC16 are missing. It
is possible that such small alterations in APC/C activity do not
critically affect unperturbed mitosis in cultured cells but that
they become decisive when the SAC is weakened or lost. Alter-
natively, other, yet to be discovered mechanisms to sustain
genome stability in the absence of SAC signaling may exist.
Interestingly, a recent study revealed that several SAC genes
are not essential in the near-haploid human cell line HAP1 even
though APC/C activity appears to be unaltered in these cells
(Raaijmakers et al., 2018). Other instances of viability in the
absence of MAD2 have been reported in murine and human cells
(Burds et al., 2005; Foijer et al., 2017; 2013), and it will be of in-
terest to dissect the properties of these MAD2 knockouts.
Both MPS1 and MAD2 act to maintain the stable euploid state
of eukaryotic genomes. In SAC signaling, MPS1 functions up-
stream of MAD2, but it also has established functions outside
of SAC signaling (Liu andWiney, 2012). We find that cells lacking
MAD2 and, thus, SAC function still require MPS1 for maintaining
their genome stability. Hence, our results indicate that SAC-inde-
pendent MPS1 functions, such as its role in chromosome align-
ment, are essential for maintaining genome integrity. Because
aneuploidy is frequently detected in human cancers (Funk
et al., 2016; Kops et al., 2005), understanding the mechanisms
controlling genome stability, such as the SAC, will advance our
knowledge of mechanisms preventing genome instability and
mechanisms underlying an increased tolerance toward ongoing
genome instability.
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Antibodies
Anti-Mad2 Antibody, clone AS55-A12 EMD Millipore Cat# MABE866
Anti-APC1 (D1E9D) Rabbit mAb Cell Signaling Technology Cat# 13329
Anti-APC2 Antibody Cell Signaling Technology Cat# 12301
Anti-APC7 Antibody Bethyl laboratories Cat# A302-551A; RRID: AB_1998911
Anti-APC8 (D5O2D) Rabbit mAb Cell Signaling Technology Cat# 15100
Anti-APC11 (D1E7Q) Rabbit mAb Cell Signaling Technology Cat# 14090
Anti-GAPDH Antibody Merck Millipore Cat# ABS16; RRID: AB_10806772
Anti-GFP (D5.1) XP Rabbit mAb Cell Signaling Technology Cat# 2956; RRID: AB_1196615
Anti-cyclin B1 Clone GNS-1 BD PharMingen Cat# 554176; RRID: AB_395287
Anti-cyclin B1 Antibody, clone GNS3 (8A5D12) Merck Millipore Cat# 05-373; RRID: AB_309701
Anti- GRB2 Clone 81/GRB2 BD Transduction Laboratories Cat# 610111; RRID: AB_397517
Anti-BubR1 Antibody Bethyl laboratories Cat# A300-995A; RRID: AB_2066087
Anti-Securin mAb Clone DCS-280 MBL Cat# K0090-3; RRID: AB_592493
Anti-phospho-Histone H3 (Ser10) Antibody Merck Millipore Cat# 06-570; RRID: AB_310177
Anti-DNA-topoisomerase II a antibody (1C5) Enzo Life Sciences Cat# ADI-KAM-CC210-E; RRID: AB_2039650
Anti-mCherry/RFP antibody Herzog et al., 2013 N/A
Anti-Cdc20 (clone E-7) antibody Santa Cruz Biotechnology Cat# sc-13162; RRID: AB_628089
Anti-APC3 antibody gift from T.U. Mayer N/A
alpha-tubulin (clone 12G10) antibody DSHB RRID: AB_1157911
Bacterial and Virus Strains
DH5a E.Coli This laboratory N/A
Chemicals, Peptides, and Recombinant Proteins
Nocodazole Sigma Aldrich Cat# M1404
reversine MedChemexpress Cat# HY-14711
ZM 447439 Cayman Chemicals Cat# 13601
RPF-Trap beads ChromoTek RFP-Trap_MA
Trypsin, Proteomics Grade Sigma Aldrich Cat# T6567
RNase A Thermo Fisher Scientific Cat# EN0531
Propidium Iodide Themo Fisher Scientific Cat# P3566
Hoechst 33342 Life Technologies Cat# H3570
TurboFect Transfection Reagent Thermo Fisher Scientific Cat# R0531
Lipofectamine RNAiMAX Transfection Reagent Thermo Fisher Scientific Cat# 13778150
Oligonucleotides
Silencer Select Negative Control #1 siRNA Thermo Fisher Scientific Cat# s813
Silencer Select MAD2 siRNA Thermo Fisher Scientific Cat# s8392
Silencer Select BUBR1 siRNA Thermo Fisher Scientific Cat# s259
See Table S2 for a list of oligonucleotide sequences This study N/A
Experimental Models: Cell Lines
See Table S3 for a list of generated cell lines This study N/A
Software and Algorithms
MaxQuant version 1.5.2.8 Cox and Mann, 2008 N/A
FlowJo 10.2 FlowJo LLC, Ashland, Oregon, USA N/A
Imaris Image Analysis Software Bitplane N/A
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
HCT116 cells (American Type Culture Collection) were cultured at 37C and 5% CO2 in Dulbecco’s modified Eagle’s medium
(Invitrogen) supplemented with 10% fetal bovine serum and penicillin/streptomycin. Cells were frequently tested for mycoplasma
contamination.
METHOD DETAILS
Flow cytometry
To analyze the cellular DNA content, exponentially growing cells were harvested at 70% confluency using trypsin. Cells were pel-
leted, resuspended in 500 mL ice-cold PBS and then permeablized by addition of 500 mL ice-cold ethanol. Samples were incubated
on ice for 45 min, pelleted by centrifugation and washed with cold PBS. The cell pellet was resuspended in a solution containing
propidium iodide (PI) (10 mg/ml PI in PBS) and RNase (25 mg/ml) and incubated for 30 min at 37C. Samples were analyzed by
flow cytometry using a BD LSR Fortessa (BD Biosciences). Data were analyzed and visualized using the FlowJo software (FlowJo,
LLC). The Cell Cycle function in FlowJo was used to quantify cell populations with different DNA content or, in case of perturbation
experiments, gates were manually set for one sample and the defined gates then applied to all samples within the same experiment.
APC/C affinity purification
APC/C was purified from APC8-mCherry expressing cells using RFP-Trap (RFP-Trap_MA, ChromoTek). For SILAC-based quan-
tification of proteins (Ong et al., 2002), cells were grown in SILAC medium supplemented with natural variants of L-arginine (Arg)
and L-lysine (Lys), i.e., Arg0/Lys0 for the light SILAC condition, or supplemented with isotope labeled variants of Arg and Lys, i.e.,
Arg6/Lys4 for the medium and Arg10/Lys8 for the heavy SILAC condition. For APC/C purification, cells were lysed in RIPA buffer
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.1% sodium-dodecyl-sulfate, 1 mM EDTA) supplemented with protease
inhibitors (Complete protease inhibitor mixture tablets, Roche Diagnostics). Lysates were incubated for 10 min on ice and cleared by
centrifugation at 16,0003 g. Cleared lysates were then incubated on a rotating wheel for 1 hour at 4Cwith 20 mL of RFP-Trap beads.
Beads were washed 3 times with RIPA buffer and eluted with LDS sample buffer (Thermo Fisher Scientific). For SILAC experiments,
equal amount of proteins, as determined by Quick Start Bradford Protein Assay (Bio-Rad), were incubated with the RFP-Trap beads.
The immunoprecipitates from the different SILAC conditions were washed separately with RIPA buffer once, and then combined into
one new tube and subsequently washed 3 times with RIPA buffer. Eluates were analyzed by SDS-PAGE followed by immunoblotting
or mass spectrometry.
Mass spectrometry
Samples in LDS sample buffer were incubated with dithiothreitol (10 mM) for 10 min at 70C and subsequently with chloroacetamide
(5.5 mM) for 60min at 25C. Proteins were separated on a 4%–12%gradient SDS-PAGE, stained with colloidal Coomassie blue, and
digested using in-gel digestion method (Jensen et al., 1999). In brief, gel lanes were cut into six pieces and each gel piece was further
sliced into smaller pieces (1mm). Gel pieces were destained with 50% ethanol in 25 mM ammonium bicarbonate (pH 8.0) on a
rotating wheel at room temperature and dehydrated with 100% ethanol. Trypsin (in 25 mM ammonium bicarbonate pH 8.0) was
added to the dry gel pieces and incubated overnight at 37C. The trypsin digestion was stopped by addition of trifluoroacetic
acid (0.5% final concentration) and peptides were extracted from the gel pieces by stepwise increase in acetonitrile concentration
(to 100% final). Next, acetonitrile was removed by centrifugal evaporation and peptides were purified by a C18 reversed-phase
packed Stage-Tip.
Peptide fractions eluted from Stage-Tips were analyzed on a quadrupole Orbitrap (Q-Exactive, Thermo Scientific) mass spectrom-
eter equipped with a nanoflow HPLC system (Thermo Scientific). Peptide samples were loaded onto C18 reversed-phase columns
and eluted with a linear gradient from 8 to 40% acetonitrile containing 0.5% acetic acid in 105 min gradient. The Q-Exactive was
operated in the data-dependent mode automatically switching between single-mass-spectrometry (MS) and tandem-mass-spec-
trometry (MS/MS) acquisition. Survey full-scan MS spectra (m/z 300–1700) were acquired in the Orbitrap. The 10 most intense
ions were sequentially isolated and fragmented by higher-energy C-trap dissociation (HCD). Peptides with unassigned charge states,
as well as peptides with charge state less than +2were excluded from fragmentation. Fragment spectra were acquired in theOrbitrap
mass analyzer.
In vitro APC/C activity assay
The in vitro ubiquitylation reactions were performed with the addition of 50 mg/ml recombinant UBE2S. Unless stated otherwise, pu-
rification of the APC/C and in-vitro ubiuquitylation reactions were performed as described previously (Hellmuth et al., 2014). To purifye2 Cell Reports 25, 2317–2328.e1–e5, November 27, 2018
active APC/C, HCT116 cells were synchronized at the G1/S boundary by the treatment with 2 mM thymidine (Sigma-Aldrich) for
20 hours, released into fresh medium for 6 hours, and then exposed to 0.2 mg/ml taxol (LC-laboratories). After 12-15 hours these
prometaphase cells were harvested by shake-off and released for 30 min by replating them into medium supplemented with ZM
447439 (4 mM, Cayman Chemicals), taxol (0.2 mg/ml), and cycloheximide (30 mg/ml, Sigma-Aldrich). For immunoprecipitation (IP)
of the APC/C, protein A Sepharose (GE Healthcare) loaded with rabbit a-APC3 (raised against a peptide with the sequence
CDADDTQLHAAESDEF) was used. To start the ubiquitylation 3 ml substrate (4.5 mg recombinant securin or 3 ml cyclinB1-CDK1
from 2,33 106 transfected cells as described below) were added to a final reaction volume of 42 ml and incubated at 37C. After 10,
25, and 45 min, 14 ml aliquots were subjected to SDS-PAGE and immunoblotted with a-securin or -cyclin B1 antibodies.
N-terminally FLAG3-Tev2 -tagged cyclin B1 and CDK1 were co-expressed in HEK293T cells by transient transfection. After 48 h
cells were harvested, lysed and subjected to immunoprecipitation using mouse anti-Flag M2-Agarose (Sigma Aldrich) as described
(Hellmuth et al., 2014). Bound protein was eluted in TEV cleavage buffer by addition of TEV-protease for 30 min at 18C (Hellmuth
et al., 2015).
CRISPR-based genome engineering
Crispr/Cas9 was applied to tag or delete genes of interest. DNA oligonucleotides encoding the guide RNAs were cloned into pX330
(Cong et al., 2013) and co-transfected with donor plasmids to achieve the desired genetic modification in HCT116 cells. Donor
plasmids generally contained homology arms spanning approximately 500 bp from each side of the cutting site (as designated by
the guide RNAs) and a selection marker, providing resistance toward puromycin, G418, zeocin, hygromycin, blasticidin or NTC
(Kochupurakkal and Iglehart, 2013). For tagging endogenous genes with mCherry, EGFP, mVenus or mCerulean3 (Markwardt
et al., 2011), DNA coding the respective fluorescent proteins was fused in frame to the last exon of the gene of interest. After selection,
clonal cell lines were analyzed by genomic PCR and/or immunoblotting to screen for the desired genomicmodification. The following
guide RNAs (including PAM motif shown in bold) were used (when two guide RNAs are listed both were used simultaneously):
For gene tagging:
APC8: ccatagttggctactctcaagcc
MAD2: aacacaatcactaaattgcacgg and tgaccttttccagcagtgagtgg
Cyclin B1: tgtaacttgtaaacttgagttgg
H2B: ccacgcatgttttcaataaatga and aatcatttcattcaaaagggggg
For gene deletions:
dAPC7: tgcgggacatggcggccgcgggg
dAPC7intron: agcgcgactgtcacatcgctagg and agctcagggacccagcctcctgg
dAPC16: gcccttttcacctaccccaaagg
dMAD2: ccctgcgcgggagcgccgaaatc
See Table S3 for a list of cell lines generated in this study.
Live cell microscopy
Cells were grown in 24 well plates suited for microscopy (Imaging Plate CG, zell-kontakt). For live cell imaging, cells were seeded into
FluoroBrite DMEM medium (Thermo Fisher Scientific) supplemented with 10% FBS and 4 mM L-glutamine. Live cell imaging
was performed on an Olympus ScanR microscope using a 20 x objective. Images were taken continuously every 3 min acquiring
6 z stacks of 1.5 mm (H2B-mCerulean3 expressing cell lines) or every 5 min acquiring 4 z stacks of 2 mm (cyclin B1-mCerulean3
and H2B-mVenus expressing cell lines). For cyclin B1-mVenus expressing cells, time-lapse imaging was performed in a heated
incubation chamber (37C) with controlled humidity and CO2 supply (5%), using a Plan-Apochromat 63x/1.4NA oil objective with
differential interference contrast, mounted on an inverted Zeiss Axio Observer Z1 microscope (Marianas Imaging Workstation
from Intelligent Imaging and Innovations Inc. (3i), Denver, CO, USA), equipped with a CSU-X1 spinning-disk confocal head
(Yokogawa Corporation of America) and four laser lines (405 nm, 488 nm, 561 nm and 640 nm). Images were detected using an
iXon Ultra 888 EM-CCD camera (Andor Technology). Fifteen 1 mm-separated z-planes were collected every 2 minutes during 1-2
hours. Reversine (1 uM) was added to the cells 2 hours prior to filming.
Measurement of SAC response by live cell imaging
Cells were grown in 35 mm glass bottom dishes (MatTek Corporation) in DMEM supplemented with 10% Fetal Bovine Serum (FBS).
To detect SAC activity, cells were treated with 100 nM nocodazole (Sigma) prior to imaging. Time-lapse imaging was performed in a
heated incubation chamber (37C) with controlled humidity and CO2 supply (5%), using a Plan-Apochromat 40x/1.4NA oil objective
with differential interference contrast, mounted on an inverted Zeiss Axio Observer Z1 microscope (Marianas Imaging Workstation
from Intelligent Imaging and Innovations Inc. (3i), Denver, CO, USA), equipped with a X-Cite 110 LEDwhite light source. Images were
detected using ORCA-Flash4.0 v2 sCMOS camera (Hamamatsu). Five 2.5 mm-separated z-planes were collected every 10 minutes
during 16 hours.Cell Reports 25, 2317–2328.e1–e5, November 27, 2018 e3
The time from NEB to anaphase was measured from the frame where chromosomes started to condense, detected with H2B-
mVenus, to the frame where chromosomes started to separate, detected with brightfield and H2B-mVenus.
RNAi
Cells were seeded into a 24-well plate and transfected with siRNAs 24 hours later using the transfection reagent RNAiMAX
(Lipofectamine) according to the manufacture’s guidelines. For MAD2 depletion, the following siRNA was used:
CGCCUUCGUUCAUUUACUAtt (Silencer Select, Thermo Fisher Scientific). Silencer Select Negative Control #1 siRNA (s813, Thermo
Fisher Scientific) was used as a negative control. The final concentration of siRNAs was 5 nM. 24 hours after siRNA transfection, cells
were trypsinized and reseeded into 24-well plates suitable formicroscopy (ImagingPlateCG, zell-kontakt). 72 hours later (96 hours after
siRNA transfection), Hoechst (Hoechst 33342, Life Technologies, H3570) was added directly to the medium and cells imaged with an
OlympusScanRmicroscopeusinga20xobjective.After imaging, cell lysateswereprepared fromthe imaged24-wellsusingRIPAbuffer
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.1% sodium-dodecyl-sulfate, 1 mM EDTA). Samples containing equal
amounts of protein, as determined by Bradford assay (Bio-Rad), were mixed with LDS-sample buffer and analyzed by SDS-PAGE
followed by immunoblotting. For live cell imaging, cells were transfected with MAD2 siRNA 32 hours prior to imaging. For BUBR1
depletion, cells were reversely transfected with control and BUBR1 siRNA (GGAUUACUGCAUUAAACGAtt, Silencer Select, Thermo
Fisher Scientific) using Lipofectamine RNAiMAX (ThermoFisher). Cells were filmed 72 hours after transfection.
Genomic analysis of APC16 locus
The genomic locus of APC16 encompassing the sequence targeted by the guide RNA was analyzed with the following primer set:
gAPC16fw (5‘-gcgcGGTACCgttcaaaacctgactgatattttggcctgagac) and gAPC16rev (5‘-gcgcCTTAAGcgtgcccagccctgactctgcctt
taacctgg). KOD Xtreme Hot Start DNA Polymerase (Novagen, Toyobo) was used according to the manufactures protocol to amplify
the APC16 locus. GeneRuler 1 kb DNA Ladder (Thermo Fisher Scientific) was used as a DNA marker. To sequence potential indels
within the APC16 locus, the PCR product was cloned into pcDNA3.1/ZEO (+) (Thermo Fisher Scientific, Invitrogen) using the KpnI and
AflII restriction sites.
Drug treatments
To assess spindle assembly checkpoint functionality, cells were treated with 100 nM or 200 nM nocodazole (Sigma Aldrich, M1404)
as indicated in the figure legends. To assay for the cellular dependence on MPS1 kinase activity, cells were treated with 0.5 mM
reversine (MedChemexpress, HY-14711) for the indicated times.
Plasmids and transfections
The coding sequence of APC16was cloned NheI/BamHI into pEGFP-N2 (Clontech), and the resulting construct (pAPC16-EGFP) was
verified by sequencing. For plasmid transfection, 5 mg of plasmid (pAPC16-EGFP) was incubated in DMEMmedium (without any sup-
plements) with 15 ul TurboFect (Thermo Fisher) for 20min at room temperature and then added to 50%confluent cells in a 10 cmdish.
APC/C affinity purification was performed 32 hours after transfection.
QUANTIFICATION AND STATISTICAL ANALYSIS
Image analysis
Images acquired by live cell microscopy were analyzed using the Imaris image analysis software (Bitplane). Nuclear cyclin B1 influx
was visually scored as the first frame prior to mitosis in which nuclear cyclin B1-mCerulean3 intensity equalled or exceeded cyto-
plasmic cyclin B1-mCerulean3 intensity. Anaphase onset was scored as the first frame in which two separate chromosome masses
were observed in the H2B-mVenus channel after metaphase plate formation. To obtain cyclin B1 degradation rates, z-projections
(median projections) were generated in Fiji and chromatin objects (Surfaces) were generated in Imaris using the Magic Wand tool
on the H2B-mVenus channel. Mean cyclin B1 -Cerulean3 intensities of the defined chromatin objects were extracted to obtain cyclin
B1 degradation trajectories for individual cells. The cyclin B1 degradation rate at anaphase onset was calculated as the slope of the
linear fit for themean cyclin B1 intensities one frame before anaphase onset, at anaphase onset, and one frame after anaphase onset.
For cyclin B1-mVenus expressing cells, which lacked a chromatin marker such as a fluorocently-tagged histone, localization of cyclin
B1 at themitotic spindle poles was guided bymicrotubules staining using 20 nM sirTubulin and 5 uM verapamil (Spirochrome) at least
2 hours prior to filming. Timing of cyclin B1 degradation was thenmeasured by establishing time = 0 as the frame in which cyclin B1 is
imported into the nucleus (prophase) and the degradation time as the frame in which cyclin B1 was not longer detectable at the spin-
dle poles (metaphase to anaphase transition). For H2B-mCerulean3 expressing cells, mitotic timing was calculated from the onset of
chromosome condensation to anaphase onset. To score chromosome segregation errors, each analyzed cell was visually scanned
through the six acquired z stacks for observable chromosome segregation defects around anaphase onset.
To analyze nuclear size and shape upon MAD2 depletion, images of Hoechst stained nuclei were visually separated into two cat-
egories: normally sized and shaped nuclei (i.e., normal nuclei), and enlarged and irregularly shaped nuclei (i.e., aberrant nuclei).e4 Cell Reports 25, 2317–2328.e1–e5, November 27, 2018
Mass spectrometry data analysis
RawMS data were analyzed by the MaxQuant software version 1.5.2.8 (Cox and Mann, 2008). Mass spectra were searched against
protein sequences from the UniProt knowledge base using the Andromeda search engine (Cox et al., 2011). Spectra were searched
with a mass tolerance of 6 ppm for precursor ions, 20 ppm for fragment ions, strict trypsin specificity and allowing up to two missed
cleavage sites. Cysteine carbamidomethylation was searched as a fixed modification, whereas amino-terminal protein acetylation
and methionine oxidation were searched as variable modifications. A false discovery rate of less than one percent was achieved
using target-decoy search strategy (Elias and Gygi, 2007) and a posterior error probability filter.Cell Reports 25, 2317–2328.e1–e5, November 27, 2018 e5
